PFPitipanage Mihika Samindi Fernando

Pitipanage Mihika Samindi Fernando

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pitipanage Mihika Samindi Fernando has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    X-linked adrenoleukodystrophy in Sri Lanka: Case series

    by D M Vidanapathirana, P M S Fernando, S Madanayake, K L S P K M Jayasena, N Atapattu, S Schröder, A B Moser, E Jasinge

  • Dihydropyrimidinase enzyme deficiency and congenital isolated adrenocorticotrophin deficiency: dual genetic diagnosis in a Sri Lankan boy

    by Shifaniya Banu Mohideen, Pitipanage Mihika Samindi Fernando, Christian Beetz, Sabine Schroder, Catarina Pereira, Senaka Gunatilleke, Pyara Rathnayake, Eresha Jasinge

    We report on a male patient who was investigated for frequent apneic episodes, feeding problems, hypotonia, and left-sided middle cerebral artery infarction in the magnetic resonance imaging at 2 weeks of age. Primary diagnosis of dihydropyrimidinase (DPYS) deficiency was suspected following the analysis of urine for organic acid; DPYS deficiency was strongly suggested by the presence of dihydrouracil, thymine, and uracil. Subsequent genetic evaluation by whole exome sequencing revealed 2 separate mutations, homozygous pathogenic variant c.1010T>C p.Leu337Pro of the DPYS gene, resulting in DPYS deficiency, and homozygous pathogenic variant c.535C>T p.Arg179* of TBX19 gene, which is associated with autosomal recessive congenital isolated adrenocorticotrophic hormone deficiency. Currently, the patient is 2 years old, and he has gross motor retardation and seizure disorder. We suggest that the clinical phenotype of the proband can be a result of mixed expression of both mutations.


  • Open Access

    Clinical, biochemical, and molecular profiles of three Sri Lankan neonates with pyruvate carboxylase deficiency

    by Eresha Jasinge, Mihika Fernando, Neluwa-Liyanage Ruwan Indika, Pyara Dilani Ratnayake, Nalin Gamaathige, Ratnanathan Ratnaranjith, Sabine Schroeder, Patricia Jones, Skrahina Volha, Subhashinie Jayasena, et al.

    Objectives: Pyruvate carboxylase, a mitochondrial enzyme, catalyses the conversion of glycolytic end-product pyruvate to tricarboxylic acid cycle intermediate, oxaloacetate. Rare pyruvate carboxylase deficiency manifests in three clinical and biochemical phenotypes: neonatal onset type A, infantile onset type B and a benign C type. The objective of this case series is to expand the knowledge of overlapping clinical and biochemical phenotypes of pyruvate carboxylase deficiency. Case presentation: We report three Sri Lankan neonates including two siblings, of two unrelated families with pyruvate carboxylase deficiency. All three developed respiratory distress within the first few hours of birth. Two siblings displayed typical biochemical findings reported in type B. The other proband with normal citrulline, lysine, moderate lactate, paraventricular cystic lesions, bony deformities, and a novel missense, homozygous variant c.2746G>C [p.(Asp916His)] in the PC gene, biochemically favoured type A. Conclusions: Our findings indicate the necessity of prompt laboratory investigations in a tachypneic neonate with coexisting metabolic acidosis, as early recognition is essential for patient management and family counselling. Further case studies are required to identify overlapping symptoms and biochemical findings in different types of pyruvate carboxylase deficiency phenotypes.


  • Open Access

    Clinical and demographic characteristics of organic acidaemias in children in a tertiary care hospital in Sri Lanka: A 4-year experience in a single centre

    by D. M. Vidanapathirana, P. M. S. Fernando, K. L. S. P. K. M. Jayasena, N. D. P. D. Chandrasiri, A. V. Gunaratne, D. Samaranayake, P. M. Jones, E. A. Jasinge

    Background: Organic acidaemias (OAs) are a biochemically heterogeneous group of inborn errors of metabolism. They are rare and infrequently reported worldwide. Most OAs are clinically apparent in the neonatal period or early infancy while some can present as a chronic progressive form or even an asymptomatic form. Objectives: To describe the clinical presentation, demographic characteristics and the incidence of OAs in Sri Lankan children. Method: A retrospective descriptive cross-sectional study was conducted over a 4-year period by reviewing records of children suspected of having OAs referred to the Department of Chemical Pathology, Lady Ridgeway Hospital. Demographic information, clinical manifestations, biochemical investigations and mutational results were recorded and analysed using descriptive statistics. Definitive diagnosis was established by gas chromatography and mass spectroscopy (GC-MS) of urine for organic acids. Results: Among the 458 patients suspected, 20 (4.3%) were confirmed to have an OA resulting in an incidence of 13/319,000 live births per year. The mean ages at onset of symptoms and diagnosis were 11.8 months (range; day 1 to 5 years) and 27.1 months (range; day 10 to 12 years) respectively. Among the 20 patients were 5 (25%) with propionic acidaemia and 4 (20%) with beta-ketothiolase deficiency. Nineteen (95%) presented acutely. Common manifestations were respiratory distress in 12 (60%) and persistent or recurrent vomiting in 10 (50%). Learning difficulty, dyskinesia and macrocephaly were some chronic manifestations. Biochemically, 15 (75%) had acidosis and 9 (45%) had ketosis. There were 13 (65%) deaths of which 6 were neonates with acute presentation. Conclusions: Propionic acidaemia and beta-ketothiolase deficiency were the common OAs identified. Common clinical presentations were respiratory distress and persistent or recurrent vomiting. Acidosis was a common biochemical finding.

  • Autosomal Recessive Renal Hypouricemia Type 2 Presenting with Childhood Stroke in a Sri Lankan Child

    by P Mihika S Fernando, R A Saraji R Gunasekara, Sabine Schröder, Christian Beetz, Anura Jayawardena, Eresha A Jasinge

    A previously healthy 14-year-old girl who was the youngest of 4 siblings with no parental consanguinity presented with sudden onset right-sided upper limb and lower limb weakness, unsteady gait, and slurred speech. On examination, there was right-sided upper motor facial nerve palsy. A brain MRI revealed a left-sided parietal lobe infarction. In the complete blood count and peripheral blood smear there was a neutrophil leukocytosis with mild left shift maturation. More than 5% of neutrophils displayed hypersegmentation. Platelets and red blood cells were normal, both quantitatively and morphologically, except for a few teardrop-shaped cells. The overall picture indicated vitamin B12 deficiency. There were no features suggestive of iron deficiency. Renal function and electrolytes were within age-matched intervals. Plasma glucose level was 4.8 mmol/L. The infection markers, including cerebrospinal fluid analysis, were normal. The coagulation screen performed as international normalized ratio/prothrombin time, activated partial thromboplastin time, and fibrinogen were unremarkable (TABLES 1 and 2).

  • Open Access

    Genotypes and phenotypes of Sri Lankan Patients with Mucopolysaccharidosis type IVA

    by Neluwa-Liyanage Indika, Ruwan Indika, Arndt Rolfs, Christian Beetz, Sabine Schröder, Catarina Pereira, Volha Volha, Mihika Fernando, Dinesha Maduri Vidanapathirana, Subhashinie Jayasena, et al.

    Mucopolysaccharidosis type IVA is a rare autosomal recessive lysosomal storage disorder occurring worldwide in all ethnic groups. It is caused by biallelic variants in the GALNS gene (OMIM 612222). We report five cases of mucopolysaccharidosis type IVA with short stature and severe skeletal dysplasia. An optimized diagnostic strategy that combined enzymatic testing and genetic screening was applied. All the tested urine samples showed increased urinary glycosaminoglycan / creatinine ratios. In all five cases, the enzyme activity of galactosamine-6-sulfate sulfatase was pathologically decreased. Gene-targeted sequencing revealed a previously unreported homozygous c.139-12T>C variant of the GALNS gene in one patient and three previously reported missense variants in four patients; c.253T>C (p.Cys85Arg), c.626C>T (p.Ala209Val) and c.878C>T (p.Ser293Leu). Genetic studies not only confirm the diagnosis of mucopolysaccharidosis IVA, but also enable predicting the prognosis and facilitate genetic counseling. Enzyme replacement therapy is not available in Sri Lanka to date. However, the quality of life in these patients can be improved by a multidisciplinary approach.

  • Open Access

    A case of cyanocobalamine responsive methylmalanoic acidemia presenting with metabolic stroke

    by M. W. A. Nimanthi, C. P. I. Kankananarachchi, H. C. Wackwella, K. D. N. Silva, U. D. S. Deshapriya, P. Gamage, M. S. Liyanarachchi, E. Jasinge, M. Fernando, S. K. Y. I. Kodikara, et al.